Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen Hires New CEO to Move Firm From Services Shop to Commercial Player

NEW YORK (GenomeWeb News) — French molecular diagnostics company IntegraGen said today it has appointed Bernard Courtieu as CEO to help the firm “accelerate its commercial efforts.”
 
“We are on the brink of emerging from a research and services firm … to a company able to quickly deliver innovative products though our pipeline and fuel further discovery,” Courtieu said.
 
The company, which focuses on diseases such as obesity, autism, diabetes, schizophrenia, and bipolar disorder, is based in Paris and formed a US subsidiary in New York in December 2006. That business is headed by former Roche executive Robert Gottlieb.
 
Courtieu was a vice president at Gemini Consulting, and he has worked as a consultant for a variety of firms. IntegraGen said Courtieu has experience in R&D, industrial operations, supply-chain management, sales and marketing, and information systems.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.